Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSX Corporation (CSX) vs Novavax Inc (NVAX) Price & Performance

CSX CorporationTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

CSX Corporation vs Novavax Inc — how do they compare? CSX Corporation trades at $50.1 (market cap $92.55B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: CSX Corporation is far larger — about 70.6× Novavax Inc's market cap, and CSX Corporation pays a 1.12% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

CSXNVAX
Market Cap
$92.55B$1.31B
Sector
IndustrialsHealth
52-Week High
$53.21$11.19
52-Week Low
$32.05$6.22
Enterprise Value
$110.52B$889.30M
Dividend Yield
1.12%

Returns comparison

Trailing returns across standard periods

About CSX Corporation

Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.

Read more on CSX

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX